Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Venetoclax, Lenalidomide and Rituximab in Patients With Relapsed/Refractory Mantle Cell Lymphoma (VALERIA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03505944
Recruitment Status : Recruiting
First Posted : April 23, 2018
Last Update Posted : July 10, 2019
Sponsor:
Information provided by (Responsible Party):
Nordic Lymphoma Group

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 1, 2020
Estimated Study Completion Date : June 1, 2022